Sergio Serrano-Villar

25PUBLICATIONS
81CO-AUTHORS
Disease surveillanceMicrobial ecologyMultiphysics flows (incl. multiphase and reacting flows)Gene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Mar 04, 2026
Beyond bacilli: integrating the microbiome into the TB research agenda.

Edson Mambuque, Ana Del Amo-de Palacios, Samuel G Huete

|Dec 09, 2025
Clarifying INSTINCT: Switching From Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Shows Comparable Inflammatory and Weight Outcomes.

Sergio Serrano-Villar, Santiago Moreno

|Nov 28, 2025
Weight Gain Among Children and Adolescents on Dolutegravir in Spain.

Blanca Bravo-Queipo-de-Llano, Luis Manuel Prieto Tato, Antoni Noguera-Julian

|Oct 10, 2025
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study).

Sergio Serrano-Villar, Laura Martín-Pedraza, Juan Tiraboschi

Pageof 5